Osworth Metformin [A product of Osworth Nigeria Limited, A Subsidiary of May and Baker Nigeria PLC]

You are here

Osworth Metformin

Osworth Metforminis an oral biguanide antidiabetic agent.

Its mode of action is thought to be multifactorial and includes delayed uptake of glucose from the gastro-intestinal tract; peripheral glucose utilization mediated by increase insulin sensitivity and inhibition of increased hepatic and renal gluconeogenesis.

 

Indication

Osworth Metformin is used for the treatment of non-insulin dependent diabetes mellitus [type 2] in adults that is non-responsive to exercise and dietary modification.

 

It is very effective in management of diabetics.

For more information, visit us on our website